key: cord-0850501-wmfhex5w
authors: Feuerstein, Assistant Professor of Medicine Joseph D.; Bilal, Mohammad; Berzin, Tyler M.; Calderwood, Audrey H.; Guturu, Praveen; Juncadella, Anna C.; Ketwaroo, Gyanprakash; Mishkin, Daniel S.; Perdue, David G.; Sekhon, Sandeep; Sengupta, Neil; Singh, Shailendra; Pleskow, Douglas K.; Sawhney, Mandeep S.
title: Triage of General Gastrointestinal Endoscopic Procedures During the COVID-19 Pandemic: Results from a National Delphi Consensus Panel
date: 2020-12-26
journal: Tech Innov Gastrointest Endosc
DOI: 10.1016/j.tige.2020.12.005
sha: e394ebbabd7c32b1025ba58679754235b5958452
doc_id: 850501
cord_uid: wmfhex5w

INTRODUCTION: As the COVID-19 pandemic moves into the post-peak period, the focus has now shifted to resuming endoscopy services to meet the needs of patients who were deferred. By using a modified Delphi process, we sought to develop a structured framework to provide guidance regarding procedure indications and procedure time intervals. METHODS: A national panel of 14 expert gastroenterologists from throughout the US used a modified Delphi process, to achieve consensus regarding: i) common indications for general endoscopy, ii) critical patient-important outcomes for endoscopy, iii) defining time-sensitive intervals, iv) assigning time-sensitive intervals to procedure indications. Two anonymous rounds of voting were allowed before attempts at consensus were abandoned. RESULTS: Expert panel reached consensus that procedures should be allocated to one of three timing categories: (1) time-sensitive emergent = scheduled within 1 week, (2) time-sensitive urgent = scheduled within 1 to 8 weeks, (3) non-time sensitive = defer to > 8 weeks and reassess timing then. The panel identified 62 common general endoscopy indications (33 for EGD, 21 for colonoscopy, 5 for sigmoidoscopy). Consensus was reached on patient-important outcomes for each procedure indication, and consensus regarding timing of the procedure indication was achieved for 74% of indications. Panelists also identified adequate personal-protective-equipment, rapid point-of-care testing, and staff training as critical pre-conditions before endoscopy services could be resumed. CONCLUSIONS: We used the validated Delphi methodology, while prioritized patient-important outcomes, to provide consensus recommendations regarding triaging a comprehensive list of general endoscopic procedures.

Background  There is consensus that all elective procedures should be cancelled during the COVID-19

pandemic.

 However, as the COVID-19 cases surge again, there is pressure to triage gastrointestinal endoscopic procedures. As the COVID-19 pandemic moves into the post-peak period, the focus has now shifted to resuming endoscopy services to meet the needs of patients who were deferred. By using a modified Delphi process, we sought to develop a structured framework to provide guidance regarding procedure indications and procedure time intervals.

Delphi process, to achieve consensus regarding: i) common indications for general endoscopy, ii) critical patient-important outcomes for endoscopy, iii) defining time-sensitive intervals, iv) assigning time-sensitive intervals to procedure indications. Two anonymous rounds of voting were allowed before attempts at consensus were abandoned.

Expert panel reached consensus that procedures should be allocated to one of three timing categories: (1) time-sensitive emergent = scheduled within 1 week, (2) time-sensitive urgent = scheduled within 1 to 8 weeks, (3) non-time sensitive = defer to > 8 weeks and reassess timing 6 then. The panel identified 62 common general endoscopy indications (33 for EGD, 21 for colonoscopy, 5 for sigmoidoscopy). Consensus was reached on patient-important outcomes for each procedure indication, and consensus regarding timing of the procedure indication was achieved for 74% of indications. Panelists also identified adequate personal-protectiveequipment, rapid point-of-care testing, and staff training as critical pre-conditions before endoscopy services could be resumed.

The SARS-CoV-2/Novel Coronavirus-19 (COVID-19) was declared a global pandemic by the World Health Organization (WHO). On March 14 th , 2020 the Surgeon General of the United States advised hospitals to cancel all elective procedures including elective endoscopy 1 . Since then, several guidelines have attempted to categorize endoscopic procedures into those that should continue to be performed, and those that could safely be deferred. A Joint GI Society

Message on COVID-19 on March 15 th , 2020 recommended classification of endoscopic procedures into urgent, non-urgent/postpone and non-urgent/perform 2 . However, no guidance was provided on which indications would fall into these respective categories.

Subsequently, a Gastroenterology Professional Society Guidance on Endoscopic Procedures recommended that all elective endoscopic procedures should be delayed, while emergent/urgent procedures should not 3 . Only broad guidance was provided on how to allocate procedural indications into these categories, and timeframe during which these procedures should be performed was not proposed. In their guidelines, the AGA recommended that all procedures should be categorized as time-sensitive (performed in less than 8 weeks) or non time-sensitive (deferred by 8 weeks or more) 4 .

While there is consensus that all life-saving endoscopic procedures should continue to be performed, no universal consensus on timing of urgent or elective procedures has been achieved 5 . Now we are entering the post-peak period of the COVID-19 pandemic, where in most parts of the United States new viral infections are slowly beginning to decrease in frequency 6 . Most centers are now gradually resuming endoscopic services. The need to determine which procedures should be prioritized, and in what timeframe is now even more critical. There are limited outcomes data regarding how long certain procedures can be safely deferred without resulting in harm. To provide more specific guidance in this area, we formed a panel of expert gastroenterologists from diverse practice settings and used a validated methodology to address the issue of procedural timing pertinent to this phase of the COVID-19 pandemic.

Our study design was as follows:

An expert panel consisting of 14 gastroenterologists were selected to emphasize diversity in geography, practice location (academic, private practice and Veterans Administration (VA)), and practice type (general gastroenterology and advanced endoscopy). 

All 4 elements of the survey mentioned above were reviewed. All responses that did not achieve consensus threshold were discussed in the first consensus video conference call.

Each response that failed to achieve consensus on the survey was open to discussion and voting. Two rounds of voting were allowed to achieve consensus with open discussions before each round of voting. If consensus was not achieved in 2 rounds, attempts at consensus for that response were abandoned. Voting was anonymous using Poll Everywhere ® 9 .

Consensus was established for two endpoints: 

A second anonymous survey was sent to the panelists asking them to place each procedural indication into one of the three categories mentioned above. Panelists were instructed to prioritize patient-important outcomes when making their decision on timing of the procedure. Panelists were also allowed to consider other outcomes but told to consider them lower in their decision-making process. Consensus threshold was set at 75%, and those responses not reaching this threshold were discussed at a second video conference call. Rules similar to those described for first video consensus conference call were used to help achieve expert consensus.

Any procedure time-sensitive interval that had not achieved consensus on the survey was then discussed and voted on. Each response that failed to achieve consensus on the survey was open to discussion and voting. The discussion included panelists sharing their views regarding why they felt the procedural indication should be triaged in the respective time interval. Two rounds of voting were allowed to achieve consensus with open discussions before each round of voting. If consensus was not achieved in 2 such rounds, attempts at consensus for that response were abandoned. The voting was completely anonymous using Poll Everywhere application.

As a part of the last survey, the panelists were asked to list measures to be able to reopen endoscopy suites or resume normal endoscopic procedures. The statements from the panelists were reviewed. During the second video conference call, these statements were discussed. The most common themes discussed were then anonymously voted on using Poll Everywhere. The recommendations to re-open the endoscopy suite were voted on as critical, important, helpful but not important, and not needed. We considered a consensus agreement was reached when over 75% of the voting members agreed on an option.

The expert panel consisted of 14 U.S. gastroenterologists and all experts who were invited to participate in the survey agreed upon first invitation. Five advanced endoscopists and 9 general gastroenterologists composed the panel. The average years in practice was 10 years (range 1- Table 1 .

The critical patient-important outcome (PIO) for each of the procedural indications was determined. There was consensus on critical PIO for each of the indications [ Table 1 -3].

Among indications for EGD, there were 7 indications for which initial consensus was not achieved, and out of which there were 6 indications for which consensus was not achieved even after re-vote (percutaneous endoscopic gastrostomy (PEG) tube placement, acute iron deficiency anemia needing hospitalization or transfusions, chronic anemia / iron deficiency anemia, esophageal narrowing / stenosis needing treatment, Barrett's esophagus with highgrade dysplasia, and stent placement for esophageal cancer). Consensus was achieved in 79% of indications. There were 7 colonoscopy indications for which initial consensus was not Table 4 .

Steps needed to re-open the endoscopy suites Panel members noted that availability of testing (e.g. antibody testing for immunity and testing for active COVID-19) would influence some recommendations. Agreed upon critical recommendations to re-open the endoscopy suite were: presence of adequate PPE and adequate training of staff to screen for COVID-19 and manage suspected COVID-19 patients.

There was no consensus among other recommendations (Table 5 ).

Our expert panel suggested that for the purposes of procedural timing while re-opening the endoscopy suites, gastrointestinal endoscopic procedures should be categorized in to one of the following: (1) Time-sensitive emergent (schedule within 1 week, (2) Time-sensitive urgent (scheduled within 1 to 8 weeks), (3) Non-time sensitive (defer to > 8 weeks and reassess timing then). We used a modified Delphi process to achieve consensus among experts in categorizing 15 62 common general gastrointestinal endoscopy indications into one of these 3 categories. We placed patient priorities at the center of this decision-making process by asking experts to prioritize patient-important outcomes. Using this approach, we were able to achieve consensus regarding procedural timing in three-fourths of the indications. We also provide a decisionmaking framework by which endoscopists can consider timing for those endoscopic procedures that are not included in this manuscript.

Our expert panel rejected terms like urgent and elective in favor of modification of AGA recommendations of categorizing procedures into time-sensitive and non-time sensitive 4 . They recommended creating three procedural categories to provide more specific guidance. Several panelists underscored the limitation of categorizing procedures into urgent and elective. There is currently no information regarding how long the COVID-19 pandemic will last, creating uncertainty among gastroenterologists as to how long "elective" procedures should be deferred, and when a reassessment of the appropriateness of the ongoing delay is needed. The expert panel therefore voted to divide the procedures into: i) time-sensitive emergent (schedule within 1 week), ii) time-sensitive urgent (schedule within 1 to 8 weeks), and iii) nontime sensitive (that can be deferred > 8 weeks, but need to reassess then). Prior recommendations for endoscopy during this pandemic focused primarily on emergent procedures, for which there is clearer consensus. For instance, there is reasonable consensus that patients presenting with non-variceal upper gastrointestinal hemorrhage should undergo an EGD within 24 hours 10 , but a patient with subacute colon obstruction needing a colon stent could in some instances be delayed if awaiting testing for COVID-19. The expert panel recognized that the majority of the indications that fall within the one-week category will likely be performed sooner than the full 7 days. In addition, having a second category of "timesensitive urgent" procedures allows for the gastroenterologists to triage procedures depending on availability of PPE, resources, staff, and the timing of the peak and surge of COVID-19 cases in the region during the pandemic. Categorizing some procedures as needing to be done within 1 to 8 weeks, can allow the gastroenterologist to schedule patients for this time interval and/or to keep a list of patients that potentially would need to be done within these 8 weeks and can be re-assessed at short intervals based on patient symptomatology and the evolving pandemic.

The expert panel underscored the limited availability of data on patient outcomes when procedures are delayed. One study showed following positive FIT testing, delaying colonoscopy up to six months does not adversely affect cancer diagnosis or advanced stage of cancer at diagnosis 11 . In contrast, we found no studies to address how long one could delay an EGD following an imaging study showing a gastric wall thickening. The absence of outcomes data balanced with the need for urgent recommendations to guide decisions make using a Delphi method ideally suited for this process. The Delphi method uses a structured process to help achieve consensus among experts. It is assumed that the collective knowledge and experience of multiple experts is likely to be superior that a single expert.

The panel chose to first achieve consensus for critical patient-important outcomes for all the procedural indications. Patient-important outcomes are outcomes that have significant impact such as mortality, therapeutic decisions, impact of function and quality of life 7, 8 . These are outcomes that patients' value. We asked the panel to consider the critical patient important outcomes as "the main motivation for patients undergo the procedure", while accepting risks and complications associated with the procedure. Medical decision-making has often been criticized for prioritizing that which is "clinically relevant" over what is "patient important" 7 . To avoid this pitfall, we asked the panelists to vote regarding timing of each procedure while strongly prioritizing the critical patient-important outcome. For example, in patients with dysplastic Barrett's esophagus, the consensus patient-important outcome was avoidance of death from esophageal cancer. During the discussion panelists recognized that the likelihood of esophageal cancer death in patients with low-grade dysplasia was substantially lower than that in patients with high-grade dysplasia 12 . Even though, the presence of any dysplasia may be cause for concern, focusing on the critical patient-important outcome and the likelihood of that outcome in each procedural setting helps gastroenterologists in determining the appropriateness of the time interval. Similarly, in patients with gastric intestinal metaplasia, the critical patient-important outcome was also avoidance of gastric cancer, but the likelihood of progression of gastric intestinal metaplasia into gastric cancer over a period of few months is very low, hence, the procedure was voted as non-time sensitive 13 .

The panel was able to achieve consensus on two critical points when considering re-opening endoscopy suites. These were 1) availability of adequate PPE and 2) adequate training of staff to screen for COVID-19 and manage suspected COVID-19 patients. These consensus recommendations provide some general guidance regarding the key considerations for resuming normal endoscopic practice in the post-pandemic era. However, final recommendations on this are beyond the scope of this panel's goals since this is an ongoing and rapidly evolving situation, with significant lack of clarity regarding the availability, feasibility, and accuracy of various testing approaches for COVID-19.

Our group conducted another study using similar methodology that focused on triaging advanced endoscopy procedures 14 . Some procedural indications were common between these two studies. In two of those indications, different timing recommendations were made by the different expert panels. For Barrett's esophagus with high-grade dysplasia and duodenal adenoma with high-grade dysplasia, the majority of the panel that consisted mostly of general GI endoscopy experts recommended that the procedure be done in 1-8 weeks, while the advanced endoscopy expert panel recommended that the procedure could be safely delayed by 8 weeks. While neither study specifically evaluated the basis for this difference, it is conceivable that the general GI endoscopy experts might be more concerned about delaying more definitive procedures to resect these lesions since they might not be performing the procedures. In contrast, advanced endoscopists who perform these procedures, might have been more comfortable with the risks of delaying the procedure further resulting in their decision to delay the procedure further. Ultimately, this highlights that expert opinion may not be a substitute for hard outcomes data. However, in a pandemic setting, the Delphi method is an extremely useful and well-validated tool that can provide timely guidance.

In conclusion, we used a structured voting process to develop consensus recommendations for triaging a comprehensive list of general endoscopic procedures as operations resume in the endoscopy suite during the current phase of the COVID-19 pandemic. While each patient's 22 

-Acute iron deficiency anemia needing hospitalizations of transfusions # -Early satiety -Esophageal narrowing / stenosis needing treatment # -Nausea and vomiting (daily/persistent) -Unexplained weight loss -Barrett's esophagus with HGD # -Duodenal adenoma with high grade dysplasia of intra-mucosal cancer -Esophageal varices for secondary prophylaxis -PEG tube placement # -Abnormal imaging suggestive of malignancy # -Bloody diarrhea / bright red blood per -rectum -Colon stricture dilation # -Iron def anemia / symptomatic anemia -Lower gastrointestinal bleeding # -Abnormal CT scan / imaging concerning for malignancy - 

Surgeon General advises hospitals to cancel elective surgeries

AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic

What constitutes urgent endoscopy? A social media snapshot of gastroenterologists' views during the COVID-19 pandemic

Current WHO phase of pandemic alert for Pandemic (H1N1)

Patient-important outcomes in registered diabetes trials

Patient-important outcomes in systematic reviews: Poor quality of evidence

Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group

Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis

ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus

AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia

Triaging advanced GI endoscopy procedures during the COVID-19 Pandemic: consensus recommendations using the Delphi method